HOUSTON, May 3 /PRNewswire/ -- IDev Technologies, Inc., an emerging
leader in the development and marketing of minimally invasive stent systems
for the treatment of peripheral vascular and non-vascular diseases, today
announces the appointment of five key officers to the Executive Team. The
Executive Team that joins Thomas M. Tully, Chairman and CEO, are Eric
Schlote, Vice President Sales, Tony Anzalone, Vice President Marketing, Tim
Placek, Vice President Regulatory, Gert Jansen, Director European Sales,
and John Dame, Controller.
Eric Schlote joins IDev Technologies, Inc. after serving as Area
Director of Sales at Fox Hollow, a Redwood City, California manufacturer of
the SilverHawk(R) artherectomy system. Eric brings great insight into the
peripheral vascular disease market segment from prior Sales Management
experience in the category. Eric holds a B.S. degree from Southwest
Missouri State as well as 11 years of category experience. In his new role,
Eric will focus on building a Sales Management team and Direct Sales
organization for the company.
Tony Anzalone was previously employed at Cyberonics Inc., a
manufacturer of Class III medical devices for epilepsy and depression, as
Senior Director, Marketing. Tony holds an MBA from New York University and
brings over 17 years of Sales and Marketing experience to IDev
Technologies, Inc. In his new role, Tony will be responsible for the
development and implementation of an organizational Marketing Plan and the
assembly of a Marketing Department to support commercialization of the new
IDEV stent technology.
Tim Placek will lead the regulatory submission process for IDev
Technologies, Inc. Previously, Tim was Senior Vice President, Regulatory
Affairs, Clinical Affairs and Quality Systems at MicroMed Technology Inc.
in Houston, Texas. Tim joins IDev Technologies, Inc. with over 12 years of
senior management experience in Regulatory Affairs and Quality Control
systems. He holds a B.A. in Speech Pathology and Audiology from the
University of South Dakota, and an ASEE degree from South Dakota State
University as an Electronic Engineer.
Gert Jansen will lead Europe as Director, European Sales for IDev
Technologies, Inc. Gert was previously Director, European Sales for
VelociMed, which was recently acquired by St. Jude Medical. Gert's
knowledge of the European marketplace is well established with a successful
track record in two other start-up ventures. Gert holds a B.S. degree in
Marketing (NIMA A/B) and brings over 20 years of management experience in
the field of medical devices.
John Dame is a CPA and joins IDev Technologies, Inc. as Controller.
John was previously at United Plastics Group, Chicago, Illinois, as a
Division Controller in Springfield, Massachusetts and offers over 20 years
of management experience in the discipline of Accounting. John holds a
B.S.B.A. from Western New England College and also manages the Human
Resources function for the company.
"In total, IDev Technologies, Inc. has acquired over 80 years of
management experience to lead the organization to future growth," stated
Thomas M. Tully, Chairman and CEO. "IDev Technologies, Inc. will continue
to focus on acquiring seasoned leadership throughout the organization to
drive the successful commercialization of our patented, innovative stent
About IDev Technologies, Inc.
IDev Technologies, Inc. ("IDEV") is an Innovator and Developer of next
generation minimally invasive medical devices for the treatment of
peripheral vascular disease (PVD). PVD is currently treated by
interventional radiologists, vascular surgeons, and cardiologists. The
Company has recently received a CE Mark approval for use of the stent in
peripheral vascular and non-vascular applications and is preparing to
launch the product in Europe shortly. The IDev Technologies, Inc. stent is
a unique device that is a self- expandable nitinol stent with significant
radial force that is resistant to kinking, crushing and fracture potential.
Additionally, the unique delivery system allows for precise placement and
repositionability prior to deployment. These features represent a
significant advance over existing stent technologies for peripheral
SOURCE IDev Technologies, Inc.